Curebound Inc.

“A copy of the Form 990 is provided to each board member for review before it is filed.”

“The Conflict of Interest Policy applies to all directors and officers of the Organization, and any person who is in a position ot exercise substantial influence over the decisions and affairs fo the Organization. All directors and officers of the Organization are required to file an annual disclosure statement wit the board of directors. If an interested person has a position of financial interest in any business or other entity with the Corporation is considering entering into an arrangement or transaction, the interested person must disclose the existence of his or her portion of financial interest and all material facts fo the Organizations board of directors as soon as the interested person has knowledge of the potential arrangement or transaction.”

“Compensation of the executive director is approved by the board of directors.”

“Any documents as stipulated by law are available to the public.”

“Any documents as stipulated by law are available to the public.”

“Compensation of the other officers and key employees are approved by the board of directors.”

“The Orgnizaton entered into a PEO relationship and thefeore reports salaries and related expenses on this line as well as consulting expenses.”

“Curebound seeks to improve life for those around the world facing cancer by developing the tools with which we prevent, diagnose, treat, and ultimately cure cancer. We believe that the San Diego community has the unique resources and spirit of collaboration to significantly improve patient outcomes and care. We are passionate about our mission of mobilizing San Diego to accelerate cures for cancer in our lifetime. Curebound is committed to investing 100 million dollars into collaborative cancer research in San Diego to make the vision of cures in our lifetime a reality. Over the last decade, since the inception of Padres Pedal the Cause, the Immunotherapy Foundation, and now Curebound, we have funded over 110 research grants that explore 87 adult cancer projects, 28 pediatric cancer projects, and 6 pioneering clinical trials, totaling over 34.5 million dollars invested. The uniqueness of our funding model is further validated by the social impact multiplier demonstrated by our grant recipients receiving 13 dollars in additional funding for every 1 dollar invested by Curebound.”

“This year alone, nearly two million people will be diagnosed with cancer, and it is the number two cause of death in the United States. Our mission is to mobilize San Diego to accelerate cures for cancer in our lifetime. And the vision of Curebound is a world without cancer. Curebound is headquartered in San Diego amidst a unique combination of three NCI cancer centers, clinical care hospitals, biotech companies, venture capital investors, philanthropic networks, and most importantly- a regional culture that embraces the spirit of collaboration. This ecosystem positions San Diego and Curebound at the forefront of discovery bringing genomic medicine, new technologies and clinical trials to market and presents an unprecedented opportunity for research collaboration. We believe that the next decade will be critical to the development of sophisticated, personalized approaches in the way we prevent, treat, and ultimately find cures for cancer.”